Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
All the news from Servier
Patient Voices: “The woman I got back after the operation was not the same”
Servier Ventures selects Cytospire Therapeutics for its first investment
#BecauseISaySo: An international campaign to keep blood pressure under control
Patient Voices: “We were very lucky!”
Servier completes the acquisition of Day One Biopharmaceuticals
Servier x L’ADN: The patient as a partner, a new figure in care
Discover Mécénat Servier Charity Fund annual report
Servier takes part in Global Industrie to discuss changes in the health care sector